These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 19909806)
1. The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension. Ferrari P Biochim Biophys Acta; 2010 Dec; 1802(12):1178-87. PubMed ID: 19909806 [TBL] [Abstract][Full Text] [Related]
2. Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation. Ferrari P; Krozowski Z Kidney Int; 2000 Apr; 57(4):1374-81. PubMed ID: 10760070 [TBL] [Abstract][Full Text] [Related]
3. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. Ferrari P; Lovati E; Frey FJ J Hypertens; 2000 Mar; 18(3):241-8. PubMed ID: 10726708 [TBL] [Abstract][Full Text] [Related]
4. Conditional Deletion of Hsd11b2 in the Brain Causes Salt Appetite and Hypertension. Evans LC; Ivy JR; Wyrwoll C; McNairn JA; Menzies RI; Christensen TH; Al-Dujaili EA; Kenyon CJ; Mullins JJ; Seckl JR; Holmes MC; Bailey MA Circulation; 2016 Apr; 133(14):1360-70. PubMed ID: 26951843 [TBL] [Abstract][Full Text] [Related]
5. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension. Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516 [TBL] [Abstract][Full Text] [Related]
6. Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2. Lovati E; Ferrari P; Dick B; Jostarndt K; Frey BM; Frey FJ; Schorr U; Sharma AM J Clin Endocrinol Metab; 1999 Oct; 84(10):3745-9. PubMed ID: 10523024 [TBL] [Abstract][Full Text] [Related]
7. Prenatal overexposure to glucocorticoids programs renal 11β-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat. Tang JI; Kenyon CJ; Seckl JR; Nyirenda MJ J Hypertens; 2011 Feb; 29(2):282-9. PubMed ID: 21045727 [TBL] [Abstract][Full Text] [Related]
13. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome? Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270 [TBL] [Abstract][Full Text] [Related]
14. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess. Atanasov AG; Ignatova ID; Nashev LG; Dick B; Ferrari P; Frey FJ; Odermatt A J Am Soc Nephrol; 2007 Apr; 18(4):1262-70. PubMed ID: 17314322 [TBL] [Abstract][Full Text] [Related]
15. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function. Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836 [TBL] [Abstract][Full Text] [Related]
16. Role of 11βHSD type 2 enzyme activity in essential hypertension and children with chronic kidney disease (CKD). Mongia A; Vecker R; George M; Pandey A; Tawadrous H; Schoeneman M; Muneyyirci-Delale O; Nacharaju V; Ten S; Bhangoo A J Clin Endocrinol Metab; 2012 Oct; 97(10):3622-9. PubMed ID: 22872687 [TBL] [Abstract][Full Text] [Related]
17. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess. Whorwood CB; Stewart PM J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678 [TBL] [Abstract][Full Text] [Related]